Chris Resburg

Chris Resburg has extensive work experience in the field of clinical operations. Chris is currently serving as the Vice President of Clinical Operations at Aditum Bio since June 2021. Prior to this, they held the position of Senior Director of Clinical Development Operations at Principia Biopharma Inc. from an unknown date in 2018 to June 2021. Chris also served as the Senior Director of Clinical Operations at Acorda Therapeutics, Inc. in South San Francisco from an unknown date in 2016 to 2018. From 2011 to 2016, Chris held various positions including Associate Director, Director, and Senior Director of Clinical Operations at Biotie Therapies. Chris worked as an Associate Director of Clinical Operations at Synosia Therapeutics, Inc. from December 2007 to February 2011. Before that, they worked as a CRA - CPM at Aryx Therapeutics from an unknown date in 2003 to 2007. Earlier in their career, Chris worked as a CRA at Winpharm Associates LLC from an unknown date in 2002 to 2003, and as a CDA & CRA at VidaMed Inc from an unknown date in 2000 to 2001. Chris began their career as a CRS - CRA at KeraVision Inc from an unknown date in 1998 to 2000.

Chris Resburg attended California State University Hayward from 1997 to 2000, where they obtained a Bachelor of Science (BS) degree in Business Administration with a focus on Finance. Chris also completed a minor in Economics during their time at the university.